相关实验视频
Updated: Jul 23, 2025

Enhancing Tumor Content through Tumor Macrodissection
Published on: February 12, 2022
扩散型大B细胞淋巴瘤的不断变化的治疗环境:挑战和愿望
Jason Yongsheng Chan1,2, Nagavalli Somasundaram3,4, Nicholas Grigoropoulos4,5
1Division of Medical Oncology, National Cancer Centre Singapore, 30 Hospital Blvd, Singapore, 168583, Singapore. jason.chan.y.s@singhealth.com.sg.
扩散性大B细胞淋巴瘤 (DLBCL) 的治疗方法已经进步,为患者提供了新的选择. 然而,现实世界的挑战,如药物获取和治疗顺序影响临床实践,特别是在新加坡.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 基因组学就是基因组学.
背景情况:
- 扩散性大B细胞淋巴瘤 (DLBCL) 是最常见的非霍奇金淋巴瘤,具有多种分子和临床病理特征.
- 最近的进展改善了对DLBCL分子格局的理解,识别了基因组亚型,这些亚型对于向治疗的开发至关重要.
研究的目的:
- 审查DLBCL治疗的最新治疗进展.
- 讨论这些进展对临床实践的影响,考虑到现实世界的挑战和新加坡医疗保健背景.
主要方法:
- 对DLBCL最近的临床试验和治疗批准的文献综述.
- 在前线和复发环境中分析当前的治疗方式.
- 讨论DLBCL管理中的实际挑战,包括药物可用性,报销和治疗顺序.
主要成果:
- 已经批准了几种新的DLBCL治疗方法,解决了以前有效治疗方法的差距.
- 尽管有治疗方面的进步,但实际实施仍面临诸如药物可用性,成本和最佳护理顺序等障碍.
- DLBCL的基因组亚型化为更个性化和更有效的向治疗提供了潜力.
结论:
- 最近的治疗进展为DLBCL患者提供了更好的选择.
- 解决药物可访问性,成本和治疗顺序方面的实际挑战对于优化DLBCL护理在现实环境中至关重要.
- 了解DLBCL的分子亚型是推进向治疗策略的关键.
更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
09:34Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
Published on: February 17, 2022
相关概念视频
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...